Delivery Order SPE2DB22D2206-SPE2DB25FJB97
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed-price arrangement with a ceiling value of $22,475.14. This non-set-aside, competitively awarded delivery order is scheduled for completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) with a ceiling value of $1,954.87. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Xifaxan 550 mg tablets in unit dose packaging (60 count) with a ceiling value of $1,625.31. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xifaxan 550 mg tablets (60-count) under a firm fixed price contract with a ceiling value of $24,364.10 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award, with performance to be executed at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,466.25 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xifaxan 550 mg tablets in unit dose packaging (60 count). This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a $36,970.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet supplies of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and irritable bowel syndrome. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg with a ceiling value of $5,936.37. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract represents a pharmaceutical supply fulfillment supporting federal medical procurement needs, with performance occurring at the contractor's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Xifaxan 550 mg tablets, a prescription medication used to treat certain gastrointestinal conditions. The total ceiling value of the order is $27,356.40, with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating open competition. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,526.92 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on July 24, 2025, with a completion date of July 25, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026....
- This federal contract award, valued at $7,409.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xifaxan 550 mg tablets, a medication used to treat certain gastrointestinal conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...